From starting material to a developed drug – a complex journey

How the cycle works traditionally:

Pharmaceutical company (sponsor)

Chemical- or biological starting material

CRO/CMO

Tests

CMO

Clinical research

Storage

In the traditional way the material (e.g. WCB, API or drug product will be stored by the manufacturer.

It´s not their core business and therefor they charge extra.

Dispatch

Neither dispatch is the manufacturers core business. Each dispatch will cost extra

Touch-points

It´s a complex journey for a molecule and each touchpoint will take extra time.

Cost

Adding up all touchpoints, cost for storage, dispatch and time will be very high for the sponsor.